Skip to main content
. 2017 Oct 17;8:740. doi: 10.3389/fphar.2017.00740

Figure 2.

Figure 2

Mean serum galcanezumab concentration profiles over time by dose cohort after single (left) and multiple (right) biweekly dose administration.